No Impact of Resistance-Associated Substitutions on the Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir for 12 Weeks in HCV DAA-experienced Patients
JOURNAL OF HEPATOLOGY(2018)
关键词
NS5A,Resistance-associated substitutions,Direct-acting antivirals,SOF,VEL,VOX,Pan-genotypic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要